A convenient synthesis of 6,6′-dimethyl-2,2′-bipyridine-4-ester and its application to the preparation of bifunctional lanthanide chelators

Aromatic and heteroaromatic azacrown compounds: advantages and disadvantages of rigid macrocyclic ligands

Current approaches to the synthesis of aromatic and heteroaromatic azamacrocycles and their derivatives are summarized and systematized. The relationship between the structure of azacrown compounds and their complexation behaviour towards metal cations is analyzed. The diversity of practical applications of azamacrocyclic derivatives in medicine, biology and analytical and organic chemistry, as well as for the design of molecular devices is demonstrated.

The bibliography includes 307 references.

Radiative Lifetime, Non-Radiative Relaxation, and Sensitization Efficiency in Luminescent Europium and Neodymium Cryptates - The Roles of 2,2'-Bipyridine-N,N'-dioxide and Deuteration

Five luminescent tris(bipyridine)-based cryptates with the lanthanoids Eu and Nd have been prepared with a systematic increase in the number of 2,2'-bipyridine-N,N'-dioxide units and with different deuteration levels in the complexing cryptands for the europium species. Careful analysis of the radiative lifetime τ_rad in these systems reveals that an increase in N-oxide units around the metal centers uniformly lowers τ_rad by about 30-40 %. The potential involvement of nephelauxetic effects is discussed. Exchange of 30 C-D for C-H oscillators around the europium centers does not affect the radiative lifetimes but decreases non-radiative deactivation and increases the overall luminescence quantum yield in D₂ O by 45 %.

Magnetic Anisotropy in Functionalized Bipyridyl Cryptates

The magnetic properties of molecular lanthanoid complexes are very important for a variety of scientific and technological applications, with the unique magnetic anisotropy being one of the most important features. In this context, a very rigid tris(bipyridine) cryptand was synthesized with a primary amine functionality for future bioconjugation. The magnetic anisotropy was investigated for the corresponding paramagnetic ytterbium cryptate. With the use of a combination of density functional theory calculations and lanthanoid-induced NMR shift analysis, the magnetic susceptibility tensor was determined and compared to the unfunctionalized cryptate analogue. The size and orientation of the axial and rhombic tensor components show remarkably great resilience toward the decrease of local symmetry around the metal and anion exchange in the inner coordination sphere. In addition, the functionalized ytterbium cryptate also exhibits efficient near-IR luminescence.

Optical and relaxometric properties of monometallic (EuIII, TbIII, GdIII) and heterobimetallic (ReI/GdIII) systems based on a functionalized bipyridine-containing acyclic ligand

The photophysical and relaxometric properties, in aqueous solution, of Ln-BPMNTA complexes and a derived Re^I/Gd^III dinuclear complex are reported in this paper.

High-denticity ligands based on picolinic acid for 111In radiochemistry

Four new acyclic ligands, Bn-H3nonapa (3), H3nonapa (4), p-NO2-Bn-H3nonapa (10), and Bn-H3trenpa (7), were synthesized and studied with nonradioactive In3+ and with radioactive 111In3+. The coordination of these ligands to In3+ was confirmed by high-resolution mass spectrometry and nuclear magnetic resonance spectroscopy. Radiolabeling experiments were performed with 111In3+; these demonstrated H3nonapa (4) to be the best indium ligand of those studied herein, achieving radiochemical yields of ∼97% in 10 min at ambient temperature, and stability to transchelation in mouse serum of 44.5% ± 25.9% after 24 h. Although the radiolabeling kinetics of H3nonapa (4) were excellent, serum stability results were inferior to the previously studied ligands DOTA, DTPA, and H4octapa, suggesting that the presented ligands may find their optimum radiopharmaceutical applications with isotopes other than 111In. Owing to the high denticity of these ligands (9–10 coordinate), they may realize their potential with large ion isotopes such as 177Lu, 86/90Y, and 225Ac.

Matching chelators to radiometals for radiopharmaceuticals

Radiometals comprise many useful radioactive isotopes of various metallic elements. When properly harnessed, these have valuable emission properties that can be used for diagnostic imaging techniques, such as single photon emission computed tomography (SPECT, e.g.(67)Ga, (99m)Tc, (111)In, (177)Lu) and positron emission tomography (PET, e.g.(68)Ga, (64)Cu, (44)Sc, (86)Y, (89)Zr), as well as therapeutic applications (e.g.(47)Sc, (114m)In, (177)Lu, (90)Y, (212/213)Bi, (212)Pb, (225)Ac, (186/188)Re). A fundamental critical component of a radiometal-based radiopharmaceutical is the chelator, the ligand system that binds the radiometal ion in a tight stable coordination complex so that it can be properly directed to a desirable molecular target in vivo. This article is a guide for selecting the optimal match between chelator and radiometal for use in these systems. The article briefly introduces a selection of relevant and high impact radiometals, and their potential utility to the fields of radiochemistry, nuclear medicine, and molecular imaging. A description of radiometal-based radiopharmaceuticals is provided, and several key design considerations are discussed. The experimental methods by which chelators are assessed for their suitability with a variety of radiometal ions is explained, and a large selection of the most common and most promising chelators are evaluated and discussed for their potential use with a variety of radiometals. Comprehensive tables have been assembled to provide a convenient and accessible overview of the field of radiometal chelating agents.

Development of a new radioligand for cholecystokinin receptor subtype 2 scintigraphy: from molecular modeling to in vivo evaluation

To improve the targeting to tumors expressing the cholecystokinin receptor subtype 2 (CCK2R) with limited kidney uptake, we synthesized a novel cholecystokinin C-terminal tetrapeptide (CCK4)-based derivative conjugated to an original bipyridine-chelator (BPCA), 111In-BPCA-(Ahx)2-CCK4. To our knowledge this is the first CCK4-based radioligand that presents a high affinity for the CCK2R, a high and specific tumor uptake, a low renal accumulation and a very good visualization of tumors in vivo compared with an internal control, 111Indium-trans-cyclohexyldiethylenetriaminepenta-acetic acid-cholecystokinin octapeptide (111In-CHX-A''-DTPA-CCK8). These properties make 111In-BPCA-(Ahx)2-CCK4, a promising candidate for imaging and peptide receptor radionuclide therapy of CCK2R positive tumors.